Johnson & Johnson COVID-19 Vaccine: FDA and CDC Ask J&J to “Pause” After Reports of Potentially Dangerous Blood Clots
Johnson and Johnson FDA Vaccine: As Advisors Recommend Authorizing a Single-Take Option, Increased COVID Stays in Balance
